Showing results (291-300 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|November 27, 2015
Do single-arm trials have a role in drug development plans incorporating randomised trials?Michael J Grayling, Adrian P ManderPharmaceutical Statistics|July 31, 2013
Bayesian methods for design and analysis of safety trialsKaren L Price, H Amy Xia, Mani Lakshminarayanan, et al.Pharmaceutical Statistics|September 10, 2015
Bayesian adaptive dose-escalation procedures for binary and continuous responses utilizing a gain functionWai Yin Yeung, John Whitehead, Bruno Reigner, et al.Pharmaceutical Statistics|January 13, 2016
Confidence intervals for the symmetry point: an optimal cutpoint in continuous diagnostic testsMónica López-Ratón, Carmen Cadarso-Suárez, Elisa M Molanes-López, et al.Pharmaceutical Statistics|January 15, 2016
Addressing potential prior-data conflict when using informative priors in proof-of-concept studiesTimothy Mutsvari, Dominique Tytgat, Rosalind WalleyPharmaceutical Statistics|January 23, 2016
Idle thoughts of a 'well-calibrated' Bayesian in clinical drug developmentAndrew P GrievePharmaceutical Statistics|December 26, 2024
A Phase I Dose-Finding Design Incorporating Intra-Patient Dose EscalationBeibei Guo, Suyu LiuPharmaceutical Statistics|December 4, 2024
Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured ConfoundingDouglas Faries, Chenyin Gao, Xiang Zhang, et al.Pharmaceutical Statistics|December 18, 2024
A Likelihood Perspective on Dose-Finding Study Designs in OncologyZhiwei ZhangPharmaceutical Statistics|December 11, 2024
Flexible Spline Models for Blinded Sample Size Reestimation in Event-Driven Clinical TrialsTim Mori, Sho Komukai, Satoshi Hattori, et al.Pageof 119